G2B-001

N/A

Report date: 2025/01/26 18:56:06

Base Information

Drug NameG2B-001
Drug Alias NameG2B-001
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuroblastomaGliomaRhabdomyosarcoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGate2Brain SL
China Registration ClassN/A

Develop Information

Active CompaniesGate2Brain SL
Inactive CompaniesN/A
Active IndicationsNeuroblastomaGliomaRhabdomyosarcoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A